The startup develops a ventricular system for managing cerebrospinal fluid in patients with hydrocephalus, specifically targeting complications from non-flowing shunts. This neurotherapeutic device enhances neurocritical care during repeat revision brain surgeries, improving patient outcomes by preventing brain damage associated with fluid mismanagement.

CRISPR QC Analytics Platform provides real-time quantitative insights into ribonucleoprotein (RNP) formation, DNA target binding kinetics, and cleavage activity to enhance the efficiency of CRISPR gene editing workflows. By enabling researchers to pre-screen gRNA efficiency and optimize RNP assembly, the platform reduces the time and costs associated with troubleshooting and iterative screening in gene editing experiments.

Develops DL Precise™, an FDA-cleared medical imaging software that uses real-time lesion-level segmentation and color contrast to improve visualization of dense breast tissue in mammograms, ultrasounds, MRIs, CTs, and X-rays. This technology reduces missed cancer diagnoses, minimizes unnecessary follow-up procedures, and increases radiology workflow efficiency by enabling precise assessment and side-by-side comparison of prior images. By integrating seamlessly into existing platforms, it enhances diagnostic accuracy without requiring additional tools or certifications.

DeepLook Medical provides an FDA‑cleared imaging solution, DL Precise™, that integrates directly into radiologists’ existing workflow to enhance visualization of soft tissue lesions.

This company provides a platform for investing in US and global markets through a mobile application. It leverages Artificial Intelligence and Machine Learning to optimize investment profitability across various products like managed portfolios, thematic portfolios, and individual stocks/ETFs. Investors gain access to internationally regulated investment products with dollarized accounts for simplified global capital deployment.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

Mindset Medical develops a digital health platform that utilizes remote photoplethysmography (rPPG) technology to transform standard cameras into contactless vital sign measurement devices. This solution eliminates the need for traditional measurement tools, enabling real-time health checks that can be securely shared with healthcare providers.

Nanodropper has developed an FDA-listed adaptor that reduces the volume of eyedrops by over 60%, addressing the issue of medication waste caused by oversized drops. This technology enables patients to use fewer drops per dose, extending the life of their medication bottles and lowering overall costs.

NowAccount provides a platform that allows businesses to receive immediate cash for their customer invoices by purchasing them at a flat fee, enabling faster access to working capital. This solution addresses the issue of delayed payments from larger clients, allowing businesses to maintain cash flow and support sustainable growth without incurring debt.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

Rivia Health provides a fully automated payment engagement platform that integrates with electronic medical records (EMR) systems to streamline patient billing communications and payment processing. By delivering real-time digital notifications and flexible payment options, Rivia Health reduces the time to payment by an average of 12 days and decreases the number of bills aging beyond 90 days by 38-69%.

The startup develops a medical platform that utilizes computational oncology to create personalized virtual tumors from diagnostic datasets, enhancing the understanding of cancer for healthcare providers. This approach enables more tailored treatment plans, improving patient outcomes in cancer care.

TruLite Health offers the Truity™ platform, which utilizes clinically integrated workflow tools and a proprietary clinical knowledge base to provide personalized, actionable clinical insights at the point of care. The platform addresses systemic health disparities by equipping healthcare providers with data-driven interventions tailored to diverse populations, thereby improving patient outcomes and fostering trust in healthcare systems.